American Heart Association In Brief: Perclose
This article was originally published in The Gray Sheet
Executive Summary
Perclose: Four hundred-patient study presented at AHA finds that the firm's Techstar percutaneous vascular surgical closure device is associated with a "statistically significant reduction of major and minor complications" versus manual compression, Perclose says. A study of 400 diagnostic catheterization patients found that major complications occurred in 0.5% of Techstar patients and 2.5% of manual compression patients. Minor complication rates were 3.9% and 10.1% for Techstar and non-Techstar patients, respectively. The study also found a reduced time to ambulation (1 hour vs. 20.3 hours) in the Techstar group. A second, 200-patient study evaluating use of Techstar in angioplasty and stent procedures also finds faster ambulation time (4.1 hours vs. 14.7 hours) in the Techstar group...